Tacrolimus—Clarithromycin Interaction in a Patient Receiving Bone Marrow Transplantation-Reference-Cited by-同舟云学术

Tacrolimus—Clarithromycin Interaction in a Patient Receiving Bone Marrow Transplantation

Published:2002-12 Issue:12 Volume:36 Page:1971-1972
ISSN:1060-0280
Container-title:Annals of Pharmacotherapy
language:en
Short-container-title:Ann Pharmacother

Author:

Ibrahim Rami B¹,Abella Esteban M²,Chandrasekar Pranathathi H³

Affiliation:

1. Clinical Pharmacy Specialist (Hematology/Oncology) Karmanos Cancer Institute/Harper University Hospital/The Detroit Medical Center Adjunct-Assistant Professor Department of Pharmacy Practice Eugene Applebaum College of Pharmacy and Allied Health Professions Wayne State University 3990 John R Detroit, Michigan 48201-2020 FAX 313/745-1628

2. Bone Marrow Transplantation Service Karmanos Cancer Institute Associate Professor of Medicine and Pediatrics School of Medicine Wayne State University

3. Division of Infectious Diseases Harper University Hospital Professor of Medicine School of Medicine Wayne State University

Publisher

SAGE Publications

Subject

Pharmacology (medical)

Link

http://journals.sagepub.com/doi/pdf/10.1345/aph.1C117

Reference9 articles.

1. Tacrolimus: An Alternative for Graft-Versus-Host Disease Prevention

2. Clinically Significant Drug Interactions with New Immunosuppressive Agents

3. Effect of intestinal P-glycoprotein on daily tacrolimus trough level in a living-donor small bowel recipient

4. Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients

5. Relationship of tacrolimus whole blood levels to efficacy and safety outcomes after unrelated donor marrow transplantation

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of clarithromycin on the pharmacokinetics of tacrolimus and expression of CYP3A4 and P‐glycoprotein in rats;Fundamental & Clinical Pharmacology;2023-03-07

2. Adult-onset hereditary myeloid malignancy and allogeneic stem cell transplantation;Frontiers in Oncology;2022-09-16

3. Signal of safety due to adverse drug reactions induced by tacrolimus with or without azithromycin;Transplant Infectious Disease;2022-04-20

4. Drug–drug interactions in patients receiving hematopoietic stem cell transplantation;Expert Opinion on Drug Metabolism & Toxicology;2018-11-27

5. Review of Major Drug-Drug Interactions in Thoracic Transplantation;Current Transplantation Reports;2018-07-10